Mansi Mane

Incidents are Analytical Incidents that occur during analytical testing that affect the quality of the product. This paper includes a study to ensure the quality and safety of drugs and also avoid future incidents. The research is based on the root cause of incidents and their patterns. To overcome these incidents, quality audits are performed. These incidents are important for the following reasons.  Product quality: Analytical incidents can impact the quality of pharmaceutical products, which can affect patient safety and efficacy. Patient safety: Inaccurate or unreliable analytical results can lead to incorrect labelling, potency, or purity of pharmaceutical products, which can harm patients.   It Ensures compliance with regulatory requirements, such as FDA, EMA, and ICH guidelines. Prevents regulatory actions, fines, or penalties. These incidents prevent financial losses due to retesting, rework, and product recalls. It prevents damage to a company's reputation and brand.&. Maintains customer trust and confidence.  The recent research is mainly focused on methods and corrective action used for accuracy, reliability, and consistency of analytical testing.  The recent themes are Data Integrity and security, which are used for maintaining digital records in the laboratory. It also includes continuous improvement and digitization, which are emerging new technologies. The main point of this article is to analyse the root cause of Incidents and corrective action taken on these analytical incidents. This topic is interesting because it brings together ethical and technological challenges that affect human health.  These analytical incidents investigate the whole process of the pharmaceutical industry.

In the pharmaceutical industry, the Change Control process typically occurs when any change is proposed or required to a product, process, equipment, or system that could potentially affect the quality, safety, or compliance of the product. This paper includes a study to ensure the quality and safety of drugs and also avoids the future risks. This research investigates the root causes of incidents within the change control process in the pharmaceutical industry, analyzing the patterns and trends that lead to non-conformances and quality deviations. It ensures that any modifications, whether planned or unplanned, are thoroughly evaluated, authorized and executed in a controlled manner to minimize disruption, risk and inefficiencies. Changes may occur at any time during the product life cycle, leading to changes in the manufacturing process, the number of materials, and  the manufacturing Location . An effective change control process is critical in the pharmaceutical industry to ensure ongoing compliance with regulatory standards, maintain product quality, and safeguard patient safety, while minimizing potential risks associated with any changes to processes, materials, or systems.